• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Windlas Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029
1,040.50 -4 (-0.39%)
  • As on 31 Mar 2025 (EOD)
  • Today’s Low

    1,025.40
  • Today’s High

    1,067.85
  • Open

    1,030.10
  • Perv Close

    1,044.60
  • 52W Low

    495.65
  • 52W High

    1,198.25

Key Indicators

  • P/E(TTM)

    35.49

  • Mar.Cap (₹Cr.)

    2,174.68

  • Div & Yield %

    0.53

  • Book Value(₹)

    225.63

  • Debt-Equity Ratio

    -0.39

  • AGM Date

    28-Mar-2025

  • EPS

    29.34

  • P/E Ratio

    35.49

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    2,174.68

  • RONW (%)

    13.66

  • ROCE (%)

    18.07

Score Board

  • Equity (₹ in Cr.)

    10.45

  • BV (₹)

    225.60

  • Sales( ₹ in Cr.)

    630.96

  • NP (in Cr.)

    58.14

  • NP Var(%)

    38.0

  • Div%

    110.0

  • CPS (₹)

    34.30

  • EPS (₹)

    27.80

  • Traded Value (₹ in Lakhs)

    2,176.14

  • 52 Week High

    1,198.25

  • 52 Week Low

    495.65

  • Price BSE

    1041.0

  • Price NSE

    1,041.00

  • Market Capital( in Cr.)

    2,176.14

  • P/C Ratio

    30.40

  • P/E Ratio

    37.40

  • Price Vs.BV

    27.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 630.96 513.08 465.93 427.60 328.85 288.20
Excise Duty 626.78 508.61 461.44 424.73 328.23 286.35
Net Sales 630.96 513.08 465.93 427.60 328.85 288.20
Other Income 13.47 9.97 6.71 3.09 0.96 2.12
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 644.42 523.05 472.64 430.70 329.81 290.32
EXPENDITURE :
Raw Materials 626.78 508.61 461.44 424.73 328.23 286.35
Power & Fuel Cost 626.78 508.61 461.44 424.73 328.23 286.35
Employee Cost 87.46 70.32 63.41 58.32 43.88 33.50
Other Manufacturing Expenses 6.63 5.41 3.78 5.18 4.70 3.74
Selling & Administrative Expenses 35.92 30.13 23.08 15.09 15.68 15.46
Miscellaneous Expenses 6.63 5.41 3.78 5.18 4.70 3.74
Less : Pre-operative Expenses Capitalised :
Total Expenditure 567.40 465.99 426.60 387.17 299.24 255.46
Operating Profit 26.67 21.53 19.96 19.91 12.33 9.82
Interest 1.10 0.79 1.42 1.29 2.37 3.64
Gross Profit 77.02 57.06 46.04 11.18 30.58 34.86
Depreciation 13.44 12.36 12.15 12.97 8.69 8.09
Profit Before Tax 77.02 57.06 46.04 11.18 30.58 34.86
Tax 17.34 14.35 10.13 4.84 8.24 12.58
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.54 0.06 -2.66 1.33 -0.13 -0.19
Reported Net Profit 58.14 42.64 38.56 5.01 22.46 22.47
Extraordinary Items 77.02 57.06 46.04 11.18 30.58 34.86
Adjusted Net Profit 58.14 42.64 38.56 5.01 22.46 22.47
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 11.44 8.32 7.63 0.00 0.00 0.00
P & L Balance carried down 58.14 42.64 38.56 5.01 22.46 22.47
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 80.00 70.00 0.00 0.00 0.00
Dividend Per Share(Rs) 5.50 4.00 3.50 0.00 0.00 0.00
Earnings Per Share-Unit Curr 27.95 19.71 18.81 2.75 35.03 38.61
Book Value 11.44 8.32 7.63 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 11.44 8.32 7.63 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    62.51%

  • Public Share Holding

    37.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,684,012 22.41 4,684,012 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,381,340 40.10 8,381,340 1
Others 0 0.00 0 0
Sub Total 13,065,352 62.51 13,065,352 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 324,468 1.55 324,468 26
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,485,346 7.11 1,485,346 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 658,747 3.15 658,747 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,468,561 11.81 2,468,561 36
2] Non Institution
Bodies Corporate 389,517 1.86 389,517 171
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 234,068 1.12 234,068 694
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 147,879 0.71 147,879 1,087
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 238,099 1.14 238,099 3
Individuals holding nominal share capital up to Rs. 1 lakh 4,263,412 20.40 4,263,412 44,570
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,366,398 25.68 5,366,398 46,547
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,900,311 100.00 20,900,311 46,590

Company Background

Windlas Biotech LtdPharmaceuticals - Indian - Formulations

  • Windlas Biotech Ltd
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029
  • Incorporation Year

    2001

  • Registered Office

    40/1 Mohabewala Industrial
    Area, Dehradun,
    Uttarakhand-248110

  • Telephone

    91-135-6608000

  • FAX

  • Chairman

    Vivek Dhariwal

  • Managing Director

    Hitesh Windlass

  • Company Secretary

    Ananta Narayan Panda

  • Auditor

    S S Kothari Mehta & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Windlas Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Windlas Biotech 1,041.20 644.42 630.96 35.49 18.03
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92